NCT03557125

Brief Summary

Evaluate difference in postoperative opiate consumption when patients do or do not receive a quadratus lumborum block preoperatively for hip arthroscopy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at below P25 for not_applicable surgery

Timeline
Completed

Started May 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 22, 2018

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

June 4, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 14, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 13, 2020

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 14, 2020

Completed
11 months until next milestone

Results Posted

Study results publicly available

February 2, 2021

Completed
Last Updated

February 2, 2021

Status Verified

January 1, 2021

Enrollment Period

1.8 years

First QC Date

June 4, 2018

Results QC Date

December 18, 2020

Last Update Submit

January 14, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Opioid Consumption

    opioid consumption including intraoperative consumption exceeding 100µg of fentanyl and all postoperative opioid consumption in the postoperative anesthesia care unit (PACU).

    24 hours

Secondary Outcomes (6)

  • Visual Analog Pain

    Immediately Post Operatively

  • Visual Analog Scale at Time of Post Anesthesia Care Unit Discharge

    2 hours

  • Post Anesthesia Care Unit Duration

    2 hours

  • Patient Satisfaction

    24 hours

  • Opioid Related Side Effects

    24 hours

  • +1 more secondary outcomes

Study Arms (2)

Receives QL Block

ACTIVE COMPARATOR

If the subject has been randomized to the block group, a subcutaneous lidocaine skin wheel placed will be placed followed by a quadratus lumborum regional block with 40 ml, 0.25% ropivacaine deposited deep to the transversus abdominus apnoneurosis and superficial to the fascia transversalis with direct ultrasound guidance. Local anesthetic will be injected in 5 ml aliquots with aspiration for blood performed before and after the injection of each aliquot. Local anesthetic injection will also be observed with real time ultrasound guidance.

Other: QL Block

Receives Saline Skin Wheel No Block

PLACEBO COMPARATOR

The skin will be cleaned with chlorhexidine. If the subject has been randomized to the "no block" group, a subcutaneous saline skin wheel will be placed and the procedure would end at this point.

Other: Saline Skin Wheel

Interventions

If the subject has been randomized to the block group, a subcutaneous lidocaine skin wheel placed will be placed followed by a quadratus lumborum regional block with 40 ml, 0.25% ropivacaine deposited deep to the transversus abdominus apnoneurosis and superficial to the fascia transversalis with direct ultrasound guidance. Local anesthetic will be injected in 5 ml aliquots with aspiration for blood performed before and after the injection of each aliquot. Local anesthetic injection will also be observed with real time ultrasound guidance.

Receives QL Block

The skin will be cleaned with chlorhexidine. If the subject has been randomized to the "no block" group, a subcutaneous saline skin wheel will be placed and the procedure would end at this point.

Receives Saline Skin Wheel No Block

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age greater than or equal to 18 years-old

You may not qualify if:

  • Local anesthetic allergy
  • Chlorhexidine allergy
  • Patient weight \< 40kg
  • Patient is currently pregnant
  • Patient is unable or chooses not to give informed consent
  • Emergency surgery
  • Known preoperative substance abuse
  • Preoperative opioid use for over three months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Location

Results Point of Contact

Title
Sylvia Wilson, MD
Organization
Medical University of South Carolina

Study Officials

  • Sylvia H Wilson, MD

    Medical University of South Carolina

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Following informed consent, all patients will be positioned, prepped and sedated for a quadratus lumborum block in the preoperative holding area to blind the patient, surgeon, intraoperative anesthesia team and data collectors. The patient will be positioned in the lateral decubitus position with the operative side up and pulse oximetry and blood pressure cuff placed for monitoring.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The patient will be positioned in the lateral decubitus position with the operative side up and pulse oximetry and blood pressure cuff placed for monitoring. The skin will be cleaned with chlorhexidine. If the subject has been randomized to the "no block" group, a subcutaneous saline skin wheel will be placed and the procedure would end at this point. If the subject has been randomized to the block group, a subcutaneous lidocaine skin wheel placed will be placed followed by a quadratus lumborum regional block with 40 ml, 0.25% ropivacaine deposited deep to the transversus abdominus apnoneurosis and superficial to the fascia transversalis with direct ultrasound guidance. Local anesthetic will be injected in 5 ml aliquots with aspiration for blood performed before and after the injection of each aliquot. Local anesthetic injection will also be observed with real time ultrasound guidance.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2018

First Posted

June 14, 2018

Study Start

May 22, 2018

Primary Completion

March 13, 2020

Study Completion

March 14, 2020

Last Updated

February 2, 2021

Results First Posted

February 2, 2021

Record last verified: 2021-01

Locations